ANIK - Anika Therapeutics, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
53.0985
-0.2115 (-0.3967%)
As of 11:33AM EST. Market open.
Stock chart is not supported by your current browser
Previous Close53.3100
Open53.1900
Bid53.2300 x 200
Ask53.5000 x 100
Day's Range53.0985 - 53.6700
52 Week Range41.6400 - 60.2900
Volume7,360
Avg. Volume71,464
Market Cap778.52M
Beta0.95
PE Ratio (TTM)25.05
EPS (TTM)2.1200
Earnings DateFeb 13, 2018 - Feb 19, 2018
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est54.00
Trade prices are not sourced from all markets
  • Capital Cube15 days ago

    ETFs with exposure to Anika Therapeutics, Inc. : November 27, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Anika Therapeutics, Inc. Here are 5 ETFs with the largest exposure to ANIK-US. Comparing the performance and risk of Anika Therapeutics, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more (Read more...)

  • Capital Cube28 days ago

    ETFs with exposure to Anika Therapeutics, Inc. : November 14, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Anika Therapeutics, Inc. Here are 5 ETFs with the largest exposure to ANIK-US. Comparing the performance and risk of Anika Therapeutics, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more (Read more...)

  • Capital Cubelast month

    ETFs with exposure to Anika Therapeutics, Inc. : November 2, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Anika Therapeutics, Inc. Here are 5 ETFs with the largest exposure to ANIK-US. Comparing the performance and risk of Anika Therapeutics, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more (Read more...)

  • Anika Therapeutics, Inc. :ANIK-US: Earnings Analysis: Q3, 2017 By the Numbers : November 1, 2017
    Capital Cubelast month

    Anika Therapeutics, Inc. :ANIK-US: Earnings Analysis: Q3, 2017 By the Numbers : November 1, 2017

    Categories: Yahoo FinanceGet free summary analysis Anika Therapeutics, Inc. reports financial results for the quarter ended September 30, 2017. We analyze the earnings along side the following peers of Anika Therapeutics, Inc. – Johnson & Johnson and Stryker Corporation (JNJ-US and SYK-US) that have also reported for this period. Highlights Summary numbers: Revenues of USD 27.18 million, ... Read more (Read more...)

  • Capital Cubelast month

    Anika Therapeutics, Inc. – Value Analysis (NASDAQ:ANIK) : October 30, 2017

    Categories: Fundamental Analysis Yahoo FinanceClick here to see latest analysis Capitalcube gives Anika Therapeutics, Inc. a score of 75. Our analysis is based on comparing Anika Therapeutics, Inc. with the following peers – Medtronic plc, Zimmer Biomet Holdings, Inc., Dynatronics Corporation, STAAR Surgical Company, Valeant Pharmaceuticals International Inc, Johnson & Johnson, Halozyme Therapeutics, Inc., Stryker Corporation and Hill-Rom Holdings, ... Read more (Read more...)

  • Anika Therapeutics, Inc. breached its 50 day moving average in a Bearish Manner : ANIK-US : October 27, 2017
    Capital Cube2 months ago

    Anika Therapeutics, Inc. breached its 50 day moving average in a Bearish Manner : ANIK-US : October 27, 2017

    Categories: ETFs Yahoo FinanceGet full CapitalCube analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for Anika Therapeutics, Inc.. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bearish Closing Price above/below 200 Day Moving Average Bullish ... Read more (Read more...)

  • Thomson Reuters StreetEvents2 months ago

    Edited Transcript of ANIK earnings conference call or presentation 26-Oct-17 1:00pm GMT

    Q3 2017 Anika Therapeutics Inc Earnings Call

  • ACCESSWIRE2 months ago

    Anika Therapeutics, Inc. to Host Earnings Call

    NEW YORK, NY / ACCESSWIRE / October 26, 2017 / Anika Therapeutics, Inc. (NASDAQ: ANIK ) will be discussing their earnings results in their Q3 Earnings Call to be held on October 26, 2017 at 9:00 AM Eastern ...

  • Associated Press2 months ago

    Anika posts 3Q profit

    The Bedford, Massachusetts-based company said it had profit of 46 cents per share. The medical technology company posted revenue of $27.2 million in the period. Anika shares have risen 20 percent since ...

  • Business Wire2 months ago

    Anika Reports Third Quarter 2017 Financial Results

    Anika Therapeutics, Inc. , a global, integrated orthopedic medicines company specializing in therapeutics based on its proprietary hyaluronic acid technology, today reported financial results for the third quarter ended September 30, 2017, along with business progress in the period.

  • Business Wire2 months ago

    Anika Completes Enrollment in Second Pivotal Phase III Trial of CINGAL for the Treatment of Knee Pain Associated with Osteoarthritis

    Anika Therapeutics, Inc. , a global, integrated orthopedics medicines company specializing in therapeutics based on its proprietary hyaluronic acid technology, today announced the completion of enrollment in its second pivotal Phase III trial evaluating CINGAL®, its novel HA-corticosteroid combination viscosupplement1 for the treatment of symptoms associated with osteoarthritis of the knee.

  • Business Wire2 months ago

    Anika Announces the Forthcoming Appointment of Thomas M. Finnerty as Chief Human Resources Officer

    Anika Therapeutics, Inc. , a global, integrated orthopedics medicines company specializing in therapeutics based on its proprietary hyaluronic acid technology, today announced the appointment of Thomas M.

  • Capital Cube2 months ago

    ETFs with exposure to Anika Therapeutics, Inc. : October 18, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Anika Therapeutics, Inc. Here are 5 ETFs with the largest exposure to ANIK-US. Comparing the performance and risk of Anika Therapeutics, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more (Read more...)

  • Business Wire2 months ago

    Anika Announces Regulatory Approval for MONOVISC® in Australia for the Treatment of Pain Associated with Osteoarthritis of all Synovial Joints

    Anika Therapeutics, Inc. , a global, integrated orthopedics medicines company specializing in therapeutics based on its proprietary hyaluronic acid technology, today announced that regulatory authorities in Australia granted approval to MONOVISC®, Anika’s single injection viscosupplement for the treatment of pain associated with osteoarthritis of all synovial joints, including the hip and knee.

  • Business Wire2 months ago

    Anika to Issue Third-Quarter 2017 Financial Results and Business Highlights on Wednesday, October 25

    Anika Therapeutics, Inc. today announced that the Company plans to issue its third-quarter 2017 financial results after the close of the market on Wednesday, October 25, 2017 and to hold a conference call the next day, Thursday, October 26, 2017, at 9:00 a.m.

  • Business Wire3 months ago

    Anika Announces Appointment of Steven Chartier as Vice President of Regulatory and Clinical Affairs

    Anika Therapeutics, Inc. , a global, integrated orthopedic medicines company specializing in therapeutics based on its proprietary hyaluronic acid technology, today announced the appointment of Steven Chartier as Vice President of Regulatory and Clinical Affairs.

  • Capital Cube4 months ago

    ETFs with exposure to Anika Therapeutics, Inc. : August 15, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Anika Therapeutics, Inc. Here are 5 ETFs with the largest exposure to ANIK-US. Comparing the performance and risk of Anika Therapeutics, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more (Read more...)

  • Zacks4 months ago

    Anika (ANIK) Grows in Orthopedic Medicines on Positive Data

    Anika Therapeutics' (ANIK) data shows HYALOFAST as an effective treatment option for cartilage lesions, suitable to all age groups.

  • Thomson Reuters StreetEvents4 months ago

    Edited Transcript of ANIK earnings conference call or presentation 27-Jul-17 1:00pm GMT

    Q2 2017 Anika Therapeutics Inc Earnings Call

  • Business Wire4 months ago

    Anika Announces Publication of Data Demonstrating the Efficacy and Safety of HYALOFAST® in Combination with Stem Cells for the Treatment of Cartilage Lesions on the Knee

    Anika Therapeutics, Inc. , a global, integrated orthopedics medicines company specializing in therapeutics based on its proprietary hyaluronic acid technology, today announced the publication of data demonstrating that HYALOFAST®, a biodegradable HA-based scaffold, used in combination with autologous adult mesenchymal stem cells , regardless of a patients’ age, is a viable and effective option for ...

  • Anika Therapeutics, Inc. :ANIK-US: Earnings Analysis: Q2, 2017 By the Numbers : August 1, 2017
    Capital Cube4 months ago

    Anika Therapeutics, Inc. :ANIK-US: Earnings Analysis: Q2, 2017 By the Numbers : August 1, 2017

    Categories: Yahoo FinanceGet free summary analysis Anika Therapeutics, Inc. reports financial results for the quarter ended June 30, 2017. We analyze the earnings along side the following peers of Anika Therapeutics, Inc. – Zimmer Biomet Holdings, Inc., Johnson & Johnson, Stryker Corporation and Hill-Rom Holdings, Inc. (ZBH-US, JNJ-US, SYK-US and HRC-US) that have also reported for this ... Read more (Read more...)

  • Business Wire5 months ago

    Anika Announces Appointment of Joseph Darling as President

    Anika Therapeutics, Inc. , a global, integrated orthopedic medicines company specializing in therapeutics based on its proprietary hyaluronic acid technology, today announced the appointment of Joseph Darling, an orthopedic and medical device veteran with broad commercial experience, to the role of President.

  • ACCESSWIRE5 months ago

    Investor Network: Anika Therapeutics, Inc. to Host Earnings Call

    NEW YORK, NY / ACCESSWIRE / July 27, 2017 / Anika Therapeutics, Inc. (NASDAQ: ANIK ) will be discussing their earnings results in their Q2 Earnings Call to be held on Thursday, July 27, 2017 at 9:00 AM ...

  • Associated Press5 months ago

    Anika posts 2Q profit

    The Bedford, Massachusetts-based company said it had net income of 76 cents per share. The medical technology company posted revenue of $33.5 million in the period. Anika shares have declined 2 percent ...

  • Business Wire5 months ago

    Anika Reports Strong Second Quarter 2017 Financial Results

    Anika Therapeutics, Inc. , a global, integrated orthopedic medicines company specializing in therapeutics based on its proprietary hyaluronic acid technology, today reported financial results for the second quarter ended June 30, 2017, along with business progress in the period.